HONG KONG and SHANGHAI and MUMBAI, India, May 3, 2021 /PRNewswire/ -- On May 2 morning, Fosun responded swiftly to India's plight and a new batch of medical protective supplies - 100,000 KN95 masks – has arrived in Mumbai from Shanghai. This is another rapid aid following Fosun's donation of 5,000 pieces of prevention supplies to Mumbai in March 2020. Shanghai and Mumbai are sister cities, and their residents are bound by their joint determination to fight the pandemic. Meanwhile, 150 Breas ventilators donated by Indian pharmaceutical company Gland Pharma, a member company of Fosun, will also be shipped to India this week.In India, the number of daily confirmed cases of COVID-19 has continued to increase since April, setting consecutive record highs, and the situation has been deteriorating. Fosun has been closely monitoring the local situation as it develops. Under the unified command and coordination of Fosun's "Global War Command Against COVID-19" team, the Mainland Chinese team and the local Indian team have worked closely to quickly organize and carry out its "global humanitarian aid plan". In less than four days, the teams managed to deploy, amass and ship 100,000 KN95 masks to help local residents of Mumbai fight the pandemic.In addition, this batch of medical aids will be used to protect our staff in India, and more than half of the supplies will be distributed by Ahuja Hive, Fosun's business platform in India, to provide the supplies for the people of local frontline health care institutions and grassroots communities so as to meet the urgent need of local communities. Since the outbreak of COVID-19, the India-based Ahuja Hive team has participated actively in the global medical supply deployment plan initiated by Fosun. It has organized many community care activities, and has donated basic daily necessities such as oil, rice, bread, and other goods to grassroots families, ensuring normal living conditions for every household.The dramatic deterioration of the COVID-19 pandemic situation in recent days reflects a severe shortage of frontline oxygen equipment in India's health care system, which has made it difficult to cope with soaring patient demand. Leveraging its global sourcing capabilities and logistics network, Fosun Trade spared no effort in deploying crucial oxygen equipment, such as oxygen concentrators, small oxygen generators, and ventilators, to India. As of today, Fosun Trade confirmed that around 20,000 small oxygen generators will arrive one after another in India. Fosun Trade will continue to ride on its global resources integration capabilities, try its best to provide medical protective supplies, nucleic acid test kits, and other necessary aid to help the world fight against COVID-19.
On January 24, 2020, Fosun launched its global medical supply deployment plan and procured close to 3 million pieces of medical supplies from more than 20 countries around the world to help COVID-19 stricken areas in China. On March 1, Fosun officially started the second phase of its operations against COVID-19, and support the global fight against the epidemic. By the end of last year, Fosun had deployed and donated more than 50 million medical protection supplies such as masks, protective suits, and nucleic acid test kits …etc, to more than 30 countries, including Italy, the United States of America, France, Germany, the United Kingdom, Portugal, Japan, South Korea, and India.Guo Guangchang, Chairman of Fosun International, said, "As a global enterprise, we firmly believe in 'a community with a shared future for mankind'. We will stand together with people across the world. We are extremely concerned about the health and safety of our staff and customers and hope to do our part to help the world defeat COVID-19 as soon as possible. As long as we unite and mutually support and help each other, I believe that we can harness the wisdom of the entire human race, and that we will definitely overcome the difficulties and defeat the virus."SOURCE Fosun
NEW YORK, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hennessy Capital Investment Corp. V (the “Company”) announced today that it priced its upsized initial public offering of 30,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “HCICU” beginning tomorrow, Friday, January 15, 2021. Each unit consists of one share of the Company’s Class A common stock and one-fourth of one redeemable warrant, each whole warrant enabling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “HCIC” and “HCICW,” respectively.
The offering is expected to close on Wednesday, January 20, 2021, subject to customary closing conditions.
The Company is a blank check company founded by Daniel J. Hennessy and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business, industry, sector or geographical location, it intends to focus its search on target businesses in the sustainable industrial technology and infrastructure industries.
Citigroup Global Markets Inc. and Barclays Capital Inc. are serving as joint book-running managers for the offering and Roth Capital Partners, LLC and Loop Capital Markets LLC are serving as co-managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 1-800-831-9146; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 888-603-5847, or by email at Barclaysprospectus@broadridge.com.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”) and was declared effective on January 14, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
CODY SLACHGateway IRP: (949) 574-3860E: HCIC@gatewayir.com